Federal government announces support for cutting-edge, AI- and robotics-enabled cell and gene therapy manufacturing

OmniaBio’s expanded facility in Hamilton seeks to drive a 5X increase in manufacturing efficiency while reducing production and supply costs by up to 50%, facilitating patient access to life-saving treatments for chronic diseases, including cancer

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top